Research Article

Comorbidities of Idiopathic Thrombocytopenic Purpura: A Population-Based Study

Table 5

Rate ratios and 95% CI between ITP and non-ITP patients for 26 grouped medical conditions.
(a)

Comorbidity groupRatio ITP/non-ITP
[ 5 4[[ 4 3[[3 2[[ 2 1[[ 1 diag[

Rate ratioLower CIUpper CIRate ratioLower CIUpper CIRate ratioLower CIUpper CIRate ratioLower CIUpper CIRate ratioLower CIUpper CI

CASMI1.40.37.40.90.24.32.70.97.83.11.09.34.01.79.5
PVD1.70.64.81.10.34.03.00.910.04.61.811.61.50.54.4
Heme2.81.35.72.21.05.03.01.46.22.11.14.04.93.27.6
RenalNA0.0NA3.60.257.37.20.779.1
Pulmonary120.111.50.07.20.779.14.81.121.41.20.34.4
Oral1.40.72.71.50.73.20.90.42.21.10.62.22.81.45.3
Ophthalmologic2.30.95.91.40.53.91.30.53.21.50.73.52.61.25.4
Neurological0.00.70.16.13.60.525.44.81.121.47.21.828.8
Neoplasm3.60.257.41.80.219.8NA0.00.70.16.1
Musculo-skeletal1.60.73.71.00.33.11.30.63.21.40.53.52.61.35.3
Mood disorder1.80.47.20.03.60.257.30.0Inf
Infections1.30.62.81.30.62.81.40.62.91.40.82.52.91.84.6
Hypoglycemia0.0NAInf0.03.60.257.3
Hypersensitivity4.81.121.41.40.37.42.70.612.10.00.70.23.3
GU3.60.717.81.20.34.42.10.67.00.40.12.01.00.33.1
GI0.90.42.31.40.72.70.90.42.01.81.03.02.41.53.9
Edema1.60.63.81.50.63.60.60.21.71.80.83.81.50.82.7
Diabetes1.40.53.90.90.32.51.80.65.31.50.63.31.60.73.4
Derm1.10.61.91.51.02.31.20.81.91.61.02.32.51.93.3
CV0.03.60.525.42.20.59.01.80.39.84.31.314.1
Constitution1.40.63.11.30.72.52.31.24.21.71.03.02.81.84.6
CHF0.02.20.59.01.10.33.92.70.97.81.00.33.1
Breast cancer3.60.257.10.90.18.0NA1.80.39.81.80.39.8
Bleeding1.30.82.11.61.02.71.81.22.82.21.53.39.06.811.9
Autoimmune3.60.717.95.40.932.6Inf1.20.111.76.11.525.4
Arrhythmia0.70.23.30.00.30.02.00.7 0.2 3.33.61.49.1

(b)

Comorbidity groupRatio ITP/non-ITP
[diag +1[[+1 +2[[+2 +3[[+3 +4[[+4 +5[

Rate ratioLower CIUpper CIRate ratioLower CIUpper CIRate ratioLower CIUpper CIRate ratioLower CIUpper CIRate ratioLower CIUpper CINtotal ITP/ year

CASMI1.90.75.60.90.24.12.00.58.01.00.19.34.40.921.64.1
PVD3.41.29.40.50.12.42.40.96.71.70.38.71.80.39.24.7
Heme3.82.26.62.41.34.55.93.011.62.00.85.20.80.22.716.4
RenalInfInf0.00.04.30.368.80.7
Pulmonary3.80.915.12.50.87.60.80.16.80.80.17.10.70.16.02.2
Oral3.61.96.83.11.56.40.50.12.21.80.65.01.00.33.69.5
Ophthalmologic2.81.45.70.90.32.81.10.33.90.90.33.11.30.44.16.5
Neurological2.40.96.20.20.01.71.80.55.72.70.89.70.60.15.03.0
NeoplasmInf0.08.00.787.80.00.01.0
Musculo-skeletal3.82.17.01.60.64.21.40.44.21.70.74.40.80.23.77.7
Mood disorder1.90.220.70.00.04.10.364.9Inf0.8
Infections1.91.23.11.70.93.02.21.14.22.00.84.50.50.12.013.5
Hypoglycemia5.70.933.82.00.221.82.60.415.80.0NA0.8
Hypersensitivity4.31.611.92.00.57.90.70.13.00.00.02.4
GU3.51.57.92.20.85.90.70.13.01.40.45.12.90.517.34.0
GI2.01.13.81.20.62.21.91.03.70.70.31.82.71.26.112.7
Edema2.41.43.90.60.21.60.20.10.90.90.32.30.70.22.38.4
Diabetes2.10.85.21.00.33.01.20.34.31.20.25.70.70.15.94.8
Derm2.51.83.61.00.71.61.61.02.61.30.82.40.90.41.930.1
CV1.90.75.00.70.12.92.20.76.60.01.20.36.02.8
Constitution2.31.63.51.10.71.91.81.03.31.60.83.11.20.53.117.6
CHF1.50.73.40.70.12.90.90.24.10.40.13.20.60.14.93.0
Breast cancer0.00.00.0Inf0.00.8
Bleeding2.92.04.13.92.65.71.71.03.00.70.31.72.31.34.240.1
Autoimmune15.41.7137.52.00.411.012.21.3117.22.10.223.30.02.3
Arrhythmia1.60.73.60.01.60.38.10.20.01.60.02.5